JG
Insider
John Greene
DirectorJohn Greene (Director) filed 1 Form 4 report in the past 24 months (1 purchase, 0 sales), most often in CRISPR Therapeutics AG (CRSP). Across 1 priced purchase filing, the average 21-session return was -12.7% from execution and -13.2% from disclosure (delay-adjusted; derived). The largest single filing was $314K of CRSP (7,000 sh × $44.85, as filed), executed Feb 26 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
-12.7%
avg across 1 priced filings
Delay-adjustediThe same average, entered at disclosure dates
-13.2%
same 1 filings, from disclosure
Filings, ttm
1
1 buys · 0 sells
Median delay
2d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$314K
shares × price, as filed
Last traded
Feb 26 2025
Filed Feb 28 2025
Median ADV $94.8M across their filed names
Open performance→Volume by month
Buys $314K
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 24 months
Most traded names
CRSPRecent filings
CRSPPURCHASE
CRISPR Therapeutics AG
View filing →
$314K7,000 sh × $44.85
Exec Feb 26 2025
Filed Feb 28 2025 · 5:30 PM ET